XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisition - Summary of Purchase Price Allocation (Details) - Bioniz
$ in Thousands
Feb. 14, 2022
USD ($)
Assets acquired:  
Cash $ 700
Prepaid expenses and other current assets 28
Fixed assets 6
Total assets acquired 734
Liabilities assumed:  
Accounts payable 265
Accrued expenses 976
Total liabilities assumed 1,241
Net liabilities acquired 507
Issuance of common stock for Bioniz acquisition 22,542
Acquired in-process research and development $ 23,049